David P. Hochman - May 16, 2024 Form 4/A Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
May 16, 2024
Transactions value $
$24,950
Form type
4/A
Date filed
5/21/2024, 09:15 PM
Date Of Original Report
May 20, 2024
Previous filing
May 10, 2024
Next filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Purchase $9.5K +2K +0.61% $4.75 330K May 16, 2024 By the DPH 2008 Trust F1, F2
transaction OBIO Common Stock Purchase $15.5K +3K +0.91% $5.15 333K May 17, 2024 By the DPH 2008 Trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 20, 2024, the Reporting Person filed a Form 4 which inadvertently misstated the transaction codes in Column 3 of Table I. This amendment is filed solely to correct the transaction codes in Column 3 of Table I to "P". The remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $5.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Chief Executive Officer and Chairperson